PT-2019-7185 · Hospira · Hospira Symbiq Infusion System

Billy Rios · Published 2019-03-23 · Updated 2019-03-25 · CVE-2015-3965

Positive Technologies (AI Summary)

CVSS v2.0

9.0

High

Base vector

AV:N/AC:L/Au:S/C:C/I:C/A:C

Name of the Vulnerable Software and Affected Versions Hospira Symbiq Infusion System versions 3.13 and earlier

Description The issue allows remote authenticated users to trigger unanticipated operations by leveraging elevated privileges for an unspecified call to an incorrectly exposed function.

Recommendations For Hospira Symbiq Infusion System versions 3.13 and earlier, at the moment, there is no information about a newer version that contains a fix for this vulnerability.

Weakness Enumeration

CWE-264

Related Identifiers

CVE-2015-3965

Affected Products

Hospira Symbiq Infusion System

References · 2

• https://nvd.nist.gov/vuln/detail/CVE-2015-3965 · Security Note
• https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01 · Note